Loss of Gα13 in B-cells linked to increased lymphoma risk due to dietary glutamine

FHS
July 29, 2024
10:15 pm

Researchers find that the deletion of Gα13 in B-cells increases lymphoma risk by enhancing proliferation in gut-associated lymph nodes. Dietary glutamine significantly promotes these effects, highlighting a crucial link between diet and cancer.

Risk Adjusted Net Present Value: What is the current valuation of Sandoz Group’s Ustekinumab Biosimilar

The revenue for Ustekinumab Biosimilar is expected to reach an annual total of $285 mn by 2028 globally based off GlobalData’s Revenue Model. The drug’s

November 4, 2023

Differing definitions of iron deficiency lead to divergent estimates of prevalence, study finds

How different ways of defining iron deficiency (ID) impact the prevalence estimates of this common disorder among women.

June 12, 2024

Evotec SE to announce results for the first nine months 2024 on 06 November 2024 – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec SE to announce results for the first nine months 2024 on 06 November 2024 30.10.2024 / 08:10

October 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.